EMCURE PHARMACEUTICALS
|
EMCURE PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹971 Cr | ₹727 Cr | ₹747 Cr | ₹973 Cr | ₹657 Cr |
| Adjustment | ₹552 Cr | ₹543 Cr | ₹492 Cr | ₹399 Cr | ₹582 Cr |
| Changes In working Capital | ₹-424 Cr | ₹51 Cr | ₹-292 Cr | ₹-292 Cr | ₹-335 Cr |
| Cash Flow after changes in Working Capital | ₹1,099 Cr | ₹1,321 Cr | ₹947 Cr | ₹1,079 Cr | ₹905 Cr |
| Cash Flow from Operating Activities | ₹852 Cr | ₹1,097 Cr | ₹747 Cr | ₹768 Cr | ₹704 Cr |
| Cash Flow from Investing Activities | ₹-94 Cr | ₹-713 Cr | ₹-468 Cr | ₹-789 Cr | ₹-252 Cr |
| Cash Flow from Financing Activities | ₹-814 Cr | ₹-164 Cr | ₹-145 Cr | ₹-152 Cr | ₹-189 Cr |
| Net Cash Inflow / Outflow | ₹-56 Cr | ₹221 Cr | ₹134 Cr | ₹-172 Cr | ₹264 Cr |
| Opening Cash & Cash Equivalents | ₹44 Cr | ₹-175 Cr | ₹-308 Cr | ₹-350 Cr | ₹-609 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | ₹214 Cr | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹-2.05 Cr | ₹-2.00 Cr | ₹-0.13 Cr | ₹0.19 Cr | ₹-4.62 Cr |
| Closing Cash & Cash Equivalent | ₹-14 Cr | ₹44 Cr | ₹-175 Cr | ₹-308 Cr | ₹-350 Cr |
Compare Cashflow Statement of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹30,907.6 Cr | 4.8% | 4.2% | 62.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹396,370.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,193.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,438.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,097.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| CIPLA | ₹97,846.7 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 4.8% |
4.2% |
62.2% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses